These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 541522)

  • 1. Secretory immunity in influenza.
    Shvartsman YS; Grigorieva SK
    J Infect Dis; 1979 Dec; 140(6):837-43. PubMed ID: 541522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of parenteral and oral immunization against influenza in a large clinical trial. 2. Results of immunologic studies].
    Tischner H; Popp M; Hien NT; Finke EJ; Nordheim W; Bräuniger S; Werchan D; Luther P; Dittmann S
    Z Erkr Atmungsorgane; 1990; 175(3):147-54. PubMed ID: 1706903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interrelationships between serum and secretory antibodies in immunization with live influenza vaccine].
    Shvartsman IaS; Krylov VA; Agranovskaia EN; Mal'tseva AI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):35-8. PubMed ID: 128269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults.
    Fujimoto C; Takeda N; Matsunaga A; Sawada A; Tanaka T; Kimoto T; Shinahara W; Sawabuchi T; Yamaguchi M; Hayama M; Yanagawa H; Yano M; Kido H
    Influenza Other Respir Viruses; 2012 Nov; 6(6):396-403. PubMed ID: 22226319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines.
    Shvartsman YS; Agranovskaya EN; Zykov MP
    J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of immunoglobulins and antibodies to haemaglutinin and neuraminidase of influenza virus in nasal secretions after natural infection.
    Hrusková J; Syrůcek L; Tůmová B; Stumpa A; Brůcková M; Losová M; Berkovicová V
    Acta Virol; 1976 Apr; 20(2):126-34. PubMed ID: 5867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16.
    Spencer MJ; Cherry JD; Terasaki PI
    N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of secretory antibodies in nonsusceptibility to influenza B disease and the prevention of the spread of this virus].
    Tsybul'skaia NV; Popova TL; Ispolatova AV; Tsybalova LM; Oleĭnikova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):81-3. PubMed ID: 6226166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
    Couch RB
    Dev Biol Stand; 1975; 28():295-306. PubMed ID: 1126573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of hemagglutination inhibiting antibodies against influenza virus A/Port Chalmers/1/73 in samples from the Roman population (1962-1974). Relation of antibody titers to those obtained against previous influenza A strains].
    Castagnari L; Delia S; Russo V; Sebastiani A
    Ann Sclavo; 1975; 17(2):129-39. PubMed ID: 1227406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of antibodies to Epstein-Barr virus (EBV) in acute viral infections.
    Gotlieb-Stematsky T; Rannon L; Vonsover A; Varsano N
    Arch Virol; 1978; 57(3):199-204. PubMed ID: 209767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.
    Kris RM; Asofsky R; Evans CB; Small PA
    J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to influenza in man.
    Couch RB; Kasel JA
    Annu Rev Microbiol; 1983; 37():529-49. PubMed ID: 6357060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper respiratory tract epithelial cells as a component of local immunity against influenza.
    Angelova LA; Angelov ZR
    Antiviral Res; 1982 Aug; 2(3):115-21. PubMed ID: 7137989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the local secretory antibody to influenza A virus infection.
    Richman DD; Murphy BR; Tierney EL; Chanock RM
    J Immunol; 1974 Nov; 113(5):1654-6. PubMed ID: 4213978
    [No Abstract]   [Full Text] [Related]  

  • 20. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
    Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
    Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.